Cite

HARVARD Citation

    Vogel, A. et al. (2020). Adjuvant 131I-metuximab in hepatocellular carcinoma: a new option for an old drug?. Lancet gastroenterology and hepatology. pp. 517-519. [Online]. 
  
Back to record